Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8309222
Reference Type
Journal Article
Title
Separation and determination of the R-isomer of etodolac in a bulk drug substance by normal-phase liquid chromatography
Author(s)
Lawande, AB
Year
2016
Publisher
Innovare Academics Sciences Pvt. Ltd
Volume
9
Issue
6
Page Numbers
327-330
Language
English
DOI
10.22159/ajpcr.2016.v9i6.14597
Abstract
Objective: The objective of this work was to develop and validate a novel, simple, rapid, and reliable analytical method for separation and determination of R-isomer impurity in Etodolac bulk drug material by normal-phase high-performance liquid chromatography (HPLC) as per International Conference on Harmonization (ICH) guidelines. Methods: The etodolac R-isomer and S-isomer were separated on a Chiralcel OD-H (150 à 4.0 mm, 5 µm) column using ethanol: n-hexane: Trifluoroacetic acid (50:50:0.1 v/v.) mobile phase with equipped detector at wavelength 225 nm and 25°C column oven temperature. The resolution between R-isomer and S-isomer was more than two recorded on the chromatogram. The specified method was developed and validated for various parameters such as reproducibility, limit of detection (LOD), limit of quantification, linearity and range, robustness, solution stability and mobile phase stability according to the ICH guidelines. Results: Linearity was found for etodolac R-isomer over the concentration range of 600-6000 ng/ml, with the linear regression (correlation coefficient R = 0.998) and proved to be robust. LOD and limit of quantification of etodolac R-isomer were found to be 200 and 600 ng/ml. The retention time of R-isomer was considered to be 2.8 minutes. The percentage recovery of etodolac R-isomer has been ranged from 97.0 to 102.0 in bulk drug material sample. The proposed analytical method has been found to be suitable, precise, reliable and accurate for the separation and quantitative determination of etodolac R-isomer in bulk drug sample. Conclusion: A novel, speedy, accurate, precise, reliable and rugged analytical method have been developed and validated for normal phase HPLC to determine R-isomer impurity in etodolac bulk drugs material as per ICH guideline. © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd.
Keywords
Etodolac; High performance liquid chromatography; Known impurity; Normal phase; Validation
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity